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In their recent report published in Science, Watson et al. (2009) describe a synthetic chemistry method to
produce specifically fluorinated aryl compounds from aryl triflates under mild reaction conditions and in
a single step. The strategy will likely prove useful to gain access to wider classes of fluorinated aromatic
compounds.
It is now widely recognized that fluorine
plays a major role in modern small-mole-
cule drug discovery (Hagmann, 2008).
The major initial focus on introducing fluo-
rine into biologically active compounds
was to reduce their in vivo metabolic turn-
over by blocking potential reactive posi-
tions with fluorine. Fluorine has a small
atom volume, and the replacement of a
hydrogen atom by fluorine is therefore
often tolerated by the target protein. This
strategy has been routinely employed,
and many marketed drugs contain
fluorine atoms that were introduced to
increase the drug half-life and exposure
in humans (Bo¨hm et al., 2004).
The introduction of fluorine also signifi-
cantly affects the physicochemical prop-
erties of compounds (Mu¨ller et al, 2007).
Fluorine is the most electronegative atom
and can therefore have strong impacts on
properties such as lipophilicity and pKa
values (Morgenthaler et al., 2007). Such
effects are increasingly used to tailor
properties of drug candidates to improve
their solubility or oral bioavailability (Filler
and Saha, 2009).
The introduction of fluorine may influ-
ence the binding affinity of the fluorinated
molecule to the target protein (Bo¨hm
et al., 2004; Mu¨ller et al, 2007). While co-
valently bound fluorine rarely acts as
a hydrogen bond acceptor from hydrogen
bond-donor groups in proteins (Dunitz,
2004), fluorine may efficiently interact
with neighboring groups through electro-
static, di- or multipolar interactions (Pau-
lini et al., 2005), which may result in the
small but distinctly increased potency of
a compound. A growing amount of data,
particularly from studies including so-
called fluorine scans (Olsen et al., 2004)
or thermodynamic double mutant cycles
(Fischer et al., 2007), suggest that favor-
able interactions involving C-F.H-C and
C-F.C=O contacts may contribute
substantially to the binding of fluorinated
molecules in hydrophobic pockets of
proteins. Thus, if a binding pocket
contains a specific location in which a
single fluorine atom can engage in several
interactions of the type mentioned above,
a significant increase in binding affinity
can be achieved (Mu¨ller et al, 2007).
However, due to its strong electronega-
tivity, fluorine may also affect the binding
affinity of a molecule indirectly by polar-
izing its neighboring parts (Bo¨hm et al.,
2004).
The synthetic access to fluorinated
compounds was difficult in the past and
largely restricted to the limited amount of
commercially available fluorinated building
blocks. Over the last two decades, an
impressive number of novel synthetic
methods for the introduction of fluorine
or fluorine-containing groups have ap-
peared, and the set of fluorine-containing
building blocks that are commercially
available has increased dramatically.
Nevertheless, there is still room for impor-
tant developments. The article by Watson
et al. (2009) opens an important avenue
toward specifically fluorinated aromatic
compounds. While methods exist for the
introduction of fluorine into aromatic
compounds, the methods require rela-
tively harsh conditions and are often not
compatible with common chemical func-
tionalities. As a consequence, fluorine
introduction had to be considered early in
the synthesis of a target compound or
available fluorinated building blocks had
to be specifically customized. Neither
strategy would be amenable to the intro-
duction of radioactive and relatively short-
lived 18F for positron-emission tomog-
raphy (PET) studies, since this requires
synthetic routes that allow facile introduc-
tion of 18F at a very late stage of a multistep
synthesis.
Based on earlier observations of limited
but regiospecific fluorine introduction by
reductive elimination from some ligand-
aryl-Pd-F intermediates, the Buchwald
group undertook a focused exploration of
this potentially interesting transformation
(Watson et al., 2009). They identified the
most suitable hydrophobic Pd-ligand,
a biaryl monophosphine ligand (tBuBrett-
Phos, shown in Figure 1), the best ways
to obtain the aryl-Pd-F intermediates,
and optimal overall reaction conditions to
provide typically high yields of the desired
regiospecifically fluorinated aryl com-
pounds in reasonably short times
(Figure 2). Gratifyingly, the established
standard procedure now offers a novel
access to fluorinated aromatic com-
pounds in a relatively mild and fast one-
step procedure from aryl triflates; this is
documented for a variety of differently
substituted benzene, indole, quinoline,
and other heteroaromatic substrates, and
appears to work even for sterically con-
gested cases. Many functional groups
Figure 1. Chemical Structure of the Ligand
tBuBrettPhos
This ligand was used in the studies by Watson et al.
(2009).
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basic groups such as amines
or carbonyl groups in ortho
position to the triflate,
possibly due to intervening
Pd-coordination of these
groups. Thus, there is still
room for further develop-
ments. More importantly, the
new procedure makes use of
CsF as source of fluorine.
This is particularly relevant
for the incorporation of radioactive 18F,
as Cs18F can be readily prepared. There-
fore, the new method presented by Wat-
son et al. (2009) offers great potential
not only for the efficient synthesis of novel
fluorinated heteroaryl compounds, but
also for the efficient preparation of suit-
able 18F-labeled compounds for PET
studies.
In addition to these obvious immediate
benefits, this novel contribution to the
synthetic armament of fluorine-organic
chemistry will allow chemists to design
more freely where they wish to incorpo-
rate fluorine atoms in complex molecules,
thus opening the door for a broad range
of new and interesting compounds that
were previously not or only sporadically
considered due to synthetic difficulties.
This will enable specifically designed
structure-property explorations. We are
convinced that this will significantly
contribute to a refined understanding
of fluorine-modulated physicochemical
properties that will have impacts much
beyond medicinal chemistry.
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Figure 2. Typical Reaction Scheme for the Synthetic Method
Developed by Watson et al. (2009).
Key advancements are the use of CsF as a source of fluorine and the biaryl
monophospine tBuBrettPhos as a hydrophobic Pd-ligand for the regiospecific
aryl fluorination by reductive elimination from ary-tBuBrettPhos-Pd(II)-F inter-
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